Investigators also want to combine ipilimumab with drugs that attack the tumour directly.
研究者也设想将ipilimumab和直接进攻肿瘤的药物结合使用。
These two researchers have been running a full-scale clinical trial of ipilimumab, an antibody that stimulates patients' immune systems to kill tumours.
他们对单克隆抗体ipilimumab进行了全面的临床研究，ipilimumab是刺激患者免疫系统进而杀灭癌症细胞的一种抗体。
Almost a quarter of those treated with ipilimumab were alive two years after treatment started. That compared with 14% of those treated just with the vaccine.
几乎四分之一的使用了ipilimumab治疗的患者自从开始治疗活了2年的时间，而相比之下只使用疫苗治疗的患者只有14%的人活那么长。
A second study showed that the recently approved drug Ipilimumab, sold under the name Yervoy, also extends survival for melanoma patients with advanced disease.
第二项研究显示Ipilimumab(商品名为Yervoy)也能延长有合并症的黑色素瘤患者生存率。
Initial trials of PLX4032 suggest it may be as good as, or even better than, ipilimumab at improving sufferers' survival. A full-scale, double-blind trial is now under way.
最初的PLX4032的试验证明它在延长患者生命方面同ipilimumab一样好，甚至比ipilimumab更好，全规模的双盲试验目前正在进行中。
Initial trials of PLX4032 suggest it may be as good as, or even better than, ipilimumab at improving sufferers' survival. A full-scale, double-blind trial is now under way.
最初的PLX4032的试验证明它在延长患者生命方面同ipilimumab一样好，甚至比ipilimumab更好，全规模的双盲试验目前正在进行中。
应用推荐